Evidence map›Paper›PMID 33803718›Full record

ReviewInternational journal of molecular sciences2021

Till Death Do Us Part-The Multifaceted Role of Platelets in Liver Diseases.

Marion Mussbacher, Laura Brunnthaler, Anja Panhuber, Patrick Starlinger, Alice Assinger

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Guideline
  2. Thromborepair: the tissue repair partner to thromboinflammation.Blood vessels, thrombosis & hemostasis · 2026
    Review
  3. Intrahepatic Platelets Orchestrate Microenvironmental Remodelling and Cellular Crosstalk in Liver Fibrosis.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Clinical value ofHeliyon · 2024
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. New and Old Key Players in Liver Cancer.International journal of molecular sciences · 2023
    Review
  19. Article
  20. The potential curative and hepatoprotective effects of platelet rich plasma on liver fibrosis inJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Marion MussbacherDepartment of Pharmacology and Toxicology, University of Graz, 8010 Graz, Austria.ORCID 0000-0001-5346-6785
Laura BrunnthalerCenter of Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.
Anja PanhuberCenter of Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.
Patrick StarlingerDepartment of Surgery, Medical University of Vienna, General Hospital, 1090 Vienna, Austria.
Alice AssingerCenter of Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-5670-5910
Medical University of Vienna · ATMayo Clinic · USUniversity of Graz · AT

Funding

Novel coagulation-dependent mechanisms of liver regeneration to detect and prevent liver dysfunction after partial hepatectomyR01DK122813 · NIDDK · MICHIGAN STATE UNIVERSITY · PI LUYENDYK, JAMES P · 2020 to 2024
$2.0M
Austrian Science Fund P-32064Austrian Science Fund FWF P 32064Medical Scientific Fund of the Mayor of the City of Vienna P-19098NIH HHS R01DK122813
6 · The paper itself

Abstract

Platelets are tightly connected with the liver, as both their production and their clearance are mediated by the liver. Platelets, in return, participate in a variety of liver diseases, ranging from non-alcoholic fatty liver diseases, (viral) hepatitis, liver fibrosis and hepatocellular carcinoma to liver regeneration. Due to their versatile functions, which include (1) regulation of hemostasis, (2) fine-tuning of immune responses and (3) release of growth factors and cellular mediators, platelets quickly adapt to environmental changes and modulate disease development, leading to different layers of complexity. Depending on the (patho)physiological context, platelets exert both beneficial and detrimental functions. Understanding the precise mechanisms through which platelet function is regulated at different stages of liver diseases and how platelets interact with various resident and non-resident liver cells helps to draw a clear picture of platelet-related therapeutic interventions. Therefore, this review summarizes the current knowledge on platelets in acute and chronic liver diseases and aims to shed light on how the smallest cells in the circulatory system account for changes in the (patho)physiology of the second largest organ in the human body.

Indexed as

Blood PlateletsHumansLiverLiver DiseasesLiver RegenerationHCCliverliver regenerationNASHnon-alcoholic fatty liver diseaseplatelets

Identifiers

PMID33803718
PMCPMC8003150
OpenAlexW3138671539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.